Search research articles
Contact Us
Filters
Showing results (51-60 of 394) with videos related to
Page
of 40
Sort By:
Annals of Internal Medicine
|
September 23, 2000
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases
S S Ellenberg, R Temple
Clinical Pharmacology and Therapeutics
|
August 21, 2008
Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
S-M Huang, R Temple
Pediatrics
|
October 8, 2014
Longitudinal association between teen sexting and sexual behavior
Jeff R Temple, HyeJeong Choi
The American Journal of Drug and Alcohol Abuse
|
January 10, 2020
Gun access, ownership, gun-related experiences, and substance use in young adults: a latent class analysis
Yu Lu, Jeff R Temple
The New England Journal of Medicine
|
December 18, 1980
The FDA's critique of the anturane reinfarction trial
R Temple, G W Pledger
Clinical Pharmacology and Therapeutics
|
February 10, 2012
The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it
R T O'Neill, R Temple
Cancer Treatment Reports
|
October 1, 1985
Food and Drug Administration requirements for approval of new anticancer drugs
J R Johnson, R Temple
Prevention Science : the Official Journal of the Society for Prevention Research
|
September 18, 2020
Dating Matters and the Future of Teen Dating Violence Prevention
Katrina J Debnam, Jeff R Temple
The American Journal of Dermatopathology
|
August 1, 1986
The fluorescence of melanocytic lesions
C R Temple-Camp, M Hainsworth
Emergency Medicine Clinics of North America
|
February 1, 1984
Observations on the current status of poison control centers in the United States
A S Manoguerra, A R Temple
Page
of 40
Search research articles
Search
Showing results (51-60 of 394) with videos related to
Sort By:
Page
of 40
Annals of Internal Medicine
|
September 23, 2000
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases
S S Ellenberg, R Temple
Clinical Pharmacology and Therapeutics
|
August 21, 2008
Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
S-M Huang, R Temple
Pediatrics
|
October 8, 2014
Longitudinal association between teen sexting and sexual behavior
Jeff R Temple, HyeJeong Choi
The American Journal of Drug and Alcohol Abuse
|
January 10, 2020
Gun access, ownership, gun-related experiences, and substance use in young adults: a latent class analysis
Yu Lu, Jeff R Temple
The New England Journal of Medicine
|
December 18, 1980
The FDA's critique of the anturane reinfarction trial
R Temple, G W Pledger
Clinical Pharmacology and Therapeutics
|
February 10, 2012
The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it
R T O'Neill, R Temple
Cancer Treatment Reports
|
October 1, 1985
Food and Drug Administration requirements for approval of new anticancer drugs
J R Johnson, R Temple
Prevention Science : the Official Journal of the Society for Prevention Research
|
September 18, 2020
Dating Matters and the Future of Teen Dating Violence Prevention
Katrina J Debnam, Jeff R Temple
The American Journal of Dermatopathology
|
August 1, 1986
The fluorescence of melanocytic lesions
C R Temple-Camp, M Hainsworth
Emergency Medicine Clinics of North America
|
February 1, 1984
Observations on the current status of poison control centers in the United States
A S Manoguerra, A R Temple
Page
of 40